Takayuki Kishi Selected Research

Takayuki Kishi Research Topics

Disease

13	Myositis (Idiopathic Inflammatory Myopathies) 01/2023 - 01/2017
8	Dermatomyositis (Dermatopolymyositis) 01/2023 - 01/2017
4	Interstitial Lung Diseases (Interstitial Lung Disease) 10/2021 - 01/2019
4	Melanoma (Melanoma, Malignant) 01/2021 - 11/2016
3	Exanthema (Rash) 01/2023 - 03/2021
2	Neoplasms (Cancer) 01/2022 - 01/2021
2	Arthralgia (Joint Pain) 01/2021 - 01/2018
2	Arthritis (Polyarthritis) 01/2021 - 01/2018
2	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 09/2020 - 01/2018
2	Polymyositis 01/2019 - 01/2018
2	Inflammation (Inflammations) 01/2018 - 03/2010
2	Abdominal Pain (Pain, Abdominal) 01/2015 - 01/2010
2	Behcet Syndrome (Behcet's Syndrome) 01/2015 - 01/2010
1	Calcinosis 01/2022
1	Erythema 03/2021
1	Lymphadenopathy 01/2021
1	Contracture 01/2021
1	Rhabdomyosarcoma 01/2021
1	Starvation 01/2021
1	Weight Loss (Weight Reduction) 01/2021
1	Dysphonia (Spastic Dysphonia) 01/2021
1	Pain (Aches) 09/2020
1	Hydrarthrosis 03/2020
1	Connective Tissue Diseases (Connective Tissue Disease) 01/2019
1	Muscle Weakness 01/2018
1	Synovitis 01/2018
1	Autoimmune Diseases (Autoimmune Disease) 01/2018
1	Contact Dermatitis (Eczema, Contact) 01/2018
1	Cryopyrin-Associated Periodic Syndromes 03/2010
1	Joint Diseases (Joint Disease) 03/2010
1	Takayasu Arteritis (Arteritis, Takayasu's) 01/2010
1	Diarrhea 01/2010
1	Fibrosis (Cirrhosis) 06/2009
1	Infantile Spasms (West Syndrome) 01/2006

Drug/Important Bio-Agent (IBA)

13	AutoantibodiesIBA 01/2023 - 01/2017
4	Adrenal Cortex Hormones (Corticosteroids)IBA 03/2021 - 06/2009
2	SS-A antibodiesIBA 01/2023 - 01/2019
2	Proteins (Proteins, Gene)FDA Link 04/2022 - 11/2016
2	nuclear matrix protein 2IBA 01/2022 - 01/2021
2	transcriptional intermediary factor 1IBA 01/2021 - 11/2018
2	Adalimumab (Humira)FDA Link 01/2018 - 01/2015
1	AntibodiesIBA 10/2021
1	SteroidsIBA 03/2021
1	Glucose (Dextrose)FDA LinkGeneric 01/2021
1	LigandsIBA 01/2021
1	NADP (NADPH)IBA 01/2021
1	amsonic acid (DAS)IBA 09/2020
1	Anti-Citrullinated Protein AntibodiesIBA 03/2020
1	Ligases (Synthetase)IBA 01/2019
1	RNA (Ribonucleic Acid)IBA 01/2019
1	Amino Acyl-tRNA Synthetases (Aminoacyl-tRNA Synthetase)IBA 01/2019
1	EnzymesIBA 01/2018
1	17,18-epoxy-5,8,11,14-eicosatetraenoic acidIBA 01/2018
1	Tacrolimus (Prograf)FDA LinkGeneric 01/2018
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2018
1	Eicosapentaenoic AcidIBA 01/2018
1	5'-Nucleotidase (5' Nucleotidase)IBA 01/2018
1	LipidsIBA 01/2018
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2018
1	Anti-Allergic Agents (Antiallergic Agents)IBA 01/2018
1	3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA)IBA 01/2017
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2017
1	Oxidoreductases (Dehydrogenase)IBA 01/2017
1	Methylprednisolone FDA LinkGeneric 01/2015
1	Interleukin-1 (Interleukin 1)IBA 03/2010
1	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 03/2010
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 03/2010
1	dimemorfan (AT 17)IBA 01/2010
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2010
1	Infliximab (Remicade)FDA Link 01/2010
1	Immunosuppressive Agents (Immunosuppressants)IBA 06/2009
1	Adrenocorticotropic Hormone (ACTH)FDA Link 01/2006
1	Therapeutic UsesIBA 01/2006

Therapy/Procedure

4	Therapeutics 01/2021 - 01/2010
1	Aftercare (After-Treatment) 03/2021